201 related articles for article (PubMed ID: 8584244)
1. A behavioral assessment of Ts65Dn mice: a putative Down syndrome model.
Escorihuela RM; Fernández-Teruel A; Vallina IF; Baamonde C; Lumbreras MA; Dierssen M; Tobeña A; Flórez J
Neurosci Lett; 1995 Oct; 199(2):143-6. PubMed ID: 8584244
[TBL] [Abstract][Full Text] [Related]
2. Impaired short- and long-term memory in Ts65Dn mice, a model for Down syndrome.
Escorihuela RM; Vallina IF; Martínez-Cué C; Baamonde C; Dierssen M; Tobeña A; Flórez J; Fernández-Teruel A
Neurosci Lett; 1998 May; 247(2-3):171-4. PubMed ID: 9655620
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of environmental enrichment on behavior and learning of male and female Ts65Dn mice, a model for Down syndrome.
Martínez-Cué C; Baamonde C; Lumbreras M; Paz J; Davisson MT; Schmidt C; Dierssen M; Flórez J
Behav Brain Res; 2002 Aug; 134(1-2):185-200. PubMed ID: 12191805
[TBL] [Abstract][Full Text] [Related]
4. Behavioral assessment of the Ts65Dn mouse, a model for Down syndrome: altered behavior in the elevated plus maze and open field.
Coussons-Read ME; Crnic LS
Behav Genet; 1996 Jan; 26(1):7-13. PubMed ID: 8852727
[TBL] [Abstract][Full Text] [Related]
5. Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome.
Rueda N; Flórez J; Martínez-Cué C
Neurosci Lett; 2008 Mar; 433(1):22-7. PubMed ID: 18226451
[TBL] [Abstract][Full Text] [Related]
6. Genetic dissection of region associated with behavioral abnormalities in mouse models for Down syndrome.
Sago H; Carlson EJ; Smith DJ; Rubin EM; Crnic LS; Huang TT; Epstein CJ
Pediatr Res; 2000 Nov; 48(5):606-13. PubMed ID: 11044479
[TBL] [Abstract][Full Text] [Related]
7. Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome.
Martínez-Cué C; Rueda N; García E; Davisson MT; Schmidt C; Flórez J
Behav Brain Res; 2005 Sep; 163(2):174-85. PubMed ID: 15941601
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes.
Stringer M; Abeysekera I; Thomas J; LaCombe J; Stancombe K; Stewart RJ; Dria KJ; Wallace JM; Goodlett CR; Roper RJ
Physiol Behav; 2017 Aug; 177():230-241. PubMed ID: 28478033
[TBL] [Abstract][Full Text] [Related]
9. Segmental trisomy as a mouse model for Down syndrome.
Davisson MT; Schmidt C; Reeves RH; Irving NG; Akeson EC; Harris BS; Bronson RT
Prog Clin Biol Res; 1993; 384():117-33. PubMed ID: 8115398
[TBL] [Abstract][Full Text] [Related]
10. Anxiety and panic responses to a predator in male and female Ts65Dn mice, a model for Down syndrome.
Martínez-Cué C; Rueda N; García E; Flórez J
Genes Brain Behav; 2006 Jul; 5(5):413-22. PubMed ID: 16879635
[TBL] [Abstract][Full Text] [Related]
11. Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities.
Sago H; Carlson EJ; Smith DJ; Kilbridge J; Rubin EM; Mobley WC; Epstein CJ; Huang TT
Proc Natl Acad Sci U S A; 1998 May; 95(11):6256-61. PubMed ID: 9600952
[TBL] [Abstract][Full Text] [Related]
12. Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome.
Rueda N; Flórez J; Martínez-Cué C
Behav Brain Res; 2008 Apr; 188(2):355-67. PubMed ID: 18178265
[TBL] [Abstract][Full Text] [Related]
13. Lack of behavioral and cognitive effects of chronic ethosuximide and gabapentin treatment in the Ts65Dn mouse model of Down syndrome.
Vidal V; García S; Martínez P; Corrales A; Flórez J; Rueda N; Sharma A; Martínez-Cué C
Neuroscience; 2012 Sep; 220():158-68. PubMed ID: 22728103
[TBL] [Abstract][Full Text] [Related]
14. The "Down syndrome critical region" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome.
Belichenko NP; Belichenko PV; Kleschevnikov AM; Salehi A; Reeves RH; Mobley WC
J Neurosci; 2009 May; 29(18):5938-48. PubMed ID: 19420260
[TBL] [Abstract][Full Text] [Related]
15. Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1).
Costa AC; Stasko MR; Schmidt C; Davisson MT
Behav Brain Res; 2010 Jan; 206(1):52-62. PubMed ID: 19720087
[TBL] [Abstract][Full Text] [Related]
16. Spatial memory deficits in segmental trisomic Ts65Dn mice.
Demas GE; Nelson RJ; Krueger BK; Yarowsky PJ
Behav Brain Res; 1996 Dec; 82(1):85-92. PubMed ID: 9021073
[TBL] [Abstract][Full Text] [Related]
17. Memantine normalizes several phenotypic features in the Ts65Dn mouse model of Down syndrome.
Rueda N; Llorens-Martín M; Flórez J; Valdizán E; Banerjee P; Trejo JL; Martínez-Cué C
J Alzheimers Dis; 2010; 21(1):277-90. PubMed ID: 20421694
[TBL] [Abstract][Full Text] [Related]
18. Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
Altafaj X; Martín ED; Ortiz-Abalia J; Valderrama A; Lao-Peregrín C; Dierssen M; Fillat C
Neurobiol Dis; 2013 Apr; 52():117-27. PubMed ID: 23220201
[TBL] [Abstract][Full Text] [Related]
19. Ts65Dn -- localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome.
Akeson EC; Lambert JP; Narayanswami S; Gardiner K; Bechtel LJ; Davisson MT
Cytogenet Cell Genet; 2001; 93(3-4):270-6. PubMed ID: 11528125
[TBL] [Abstract][Full Text] [Related]
20. Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome.
Corrales A; Martínez P; García S; Vidal V; García E; Flórez J; Sanchez-Barceló EJ; Martínez-Cué C; Rueda N
J Pineal Res; 2013 Apr; 54(3):346-58. PubMed ID: 23350971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
